Drug wholesaler AmerisourceBergen Corp. said on Wednesday it acquired Brecon Pharmaceuticals Ltd., a privately held, United Kingdom-based provider of contract packaging and clinical trial materials services, for about $49 million in cash.
*For more on this story,
read the full Reuters article.
